The human estrogen receptor-α isoform hERα46 antagonizes the proliferative influence of hERα66 in MCF7 breast cancer cells

Endocrinology

Volumn 146, Issue 12, 2005, Pages 5474-5484

  Penot, Graziella ^a   Le Péron, Christine ^a   Mérot, Yohann ^a   Grimaud Fanouillére, Eva ^a   Ferriére, François ^a   Boujrad, Noureddine ^a   Kah, Olivier ^a   Saligaut, Christian ^a   Ducouret, Bernadette ^a   Métivier, Raphaël ^a   Flouriot, Gilles ^a,b  

^a CNRS   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; MITOGENIC AGENT;

ARTICLE; BREAST CANCER; CANCER GROWTH; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN; CONTROLLED STUDY; HUMAN; HUMAN CELL; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BINDING, COMPETITIVE; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; DIMERIZATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; G0 PHASE; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; RESPONSE ELEMENTS; TISSUE DISTRIBUTION;

EID: 27844443060     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0866     Document Type: Article

References (52)

1. Norman AW, Litwack G 1987 Estrogens and progestins. In: Litwack G, eds. Hormones. London: Academic Press Inc.; 550-560
2. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G, Enmark E, Pettersson K, Warner M, Gustafsson JA 2001 Mechanisms of estrogen action. Physiol Rev 81:1535-1565
3. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG 1983 Hormonal risk factors, breast tissue age and the age-induce of breast cancer. Nature 303:767-770
4. Henderson BE, Ross R, Bernstein L 1988 Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res 48:246-253
5. Sutherland R, Reddel RR, Green MD 1983 Effects of œstrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antiœstrogens. Eur J Cancer Clin Oncol 19:307-318
6. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P 1986 Human estrogen receptor cDNA: sequence, expression and homology to verbA. Nature 320:134-139
7. Kuiper GJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA 1996 Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93:5925-5930
8. Mosselman S, Polman J, Dijkema R 1996 ERβ: identification and characterization of a novel human receptor. FEBS Lett 392:49-53
9. Couse JF, Korach KS 1999 Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20:358-417
10. McGuire WL, Clark GM, Dressler LG, Owens MA 1986 Role of steroid hormone receptors as prognostic factors in primary breast cancer. NCI Monogr 1:19-23
11. Dickson R, Lippman M 1988 Control of human breast cancer by estrogen, growth factors, and oncogenes. In: Lippman M, Dickson R, eds. Breast cancer: cellular and molecular biology. Boston: Kluwer; 119-165
12. Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P 2004 Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 11:537-551
13. Beato M 1989 Gene regulation by steroid hormones. Cell 56:335-344
14. Berry M, Metzger D, Chambon P 1990 Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9:2811-2818
15. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike WJ, McDonnell DP 1994 Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30
16. Norris JD, Fan D, Kerner SA, McDonnell DP 1997 Identification of a third autonomous activation domain within the human estrogen receptor. Mol Endocrinol 11:747-754
17. O'Lone R, Frith MC, Karlsson EK, Hansen U 2004 Genomic targets of nuclear estrogen receptors. Mol Endocrinol 18:1859-1875
18. McKenna NJ, O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465-474
19. Belandia B, Parker MG 2003 Nuclear receptors: a rendezvous for chromatin remodeling factors. Cell 114:277-280
20. Métivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F 2003 Estrogen receptor-αdirects ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763
21. Sabbah M, Courilleau D, Mester J, Redeuilh G 1999 Estrogen induction of the cyclinD1 promoter: involvement of a cAMP response-like element. Proc Natl Acad Sci USA 96:11217-11222
22. Weisz A, Rosales R 1990 Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor. Nucleic Acids Res 18:50097-50106
23. Dubik D, Shiu RP 1992 Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7:1587-1594
24. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y 1994 Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 269:16433-16442
25. Migliaccio A, Di Domenico M, Castoria G, De Falco A, Bontempo P, Nola E, Auricchio F 1996 Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 15:1292-1300
26. Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V, Gannon F 2000 Identification of a new isoform of the human estrogen receptor-α (hER-α) that is encoded by distinct transcripts and that is able to repress hER-α activation function 1. EMBO J 19:4688-4700
27. Denger S, Reid G, Kos M, Flouriot G, Parsch D, Brand H, Korach KS, Sonntag-Buck V, Gannon F 2001 ERα gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol Endocrinol 15:2064-2077
28. Figtree GA, McDonald D, Watkins H, Channon KM 2003 Truncated estrogen receptor α 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 107:120-126
29. Li L, Haynes P, Bender JR 2003 Plasma membrane localization and function of the estrogen receptor α variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100:4807-4812
30. Métivier R, Stark A, Flouriot G, Hubner MR, Brand H, Penot G, Manu D, Denger S, Reid G, Kos M, Russell RB, Kah O, Pakdel F, Gannon F 2002 A dynamic structural model for estrogen receptor-α activation by ligands, emphasizing the role of interactions between distant A and E domains. Mol Cell 10:1019-1032
31. Métivier R, Penot G, Carmouche RP, Hubner MR, Reid G, Denger S, Manu D, Brand H, Kos M, Benes V, Gannon F 2004 Transcriptional complexes engaged by apo-estrogen receptor-α isoforms have divergent outcomes. EMBO J 23:3653-3666
32. Métivier R, Penot G, Flouriot G, Pakdel F 2001 coactivator protein-1: requirement for the AF-1 α-helical core and for a direct interaction between the N- and C-terminal domains. Mol Endocrinol 15:1953-1970
33. Merot Y, Métivier R, Penot G, Manu D, Saligaut C, Gannon F, Pakdel F, Kah O, Flouriot G 2004 The relative contribution exerted by AF-1 and AF-2 transactivation functions in estrogen receptor α transcriptional activity depends upon the differentiation stage of the cell. J Biol Chem 279:26184-26191
34. Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM 2001 Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells. Proc Natl Acad Sci USA 97:9042-9046
35. Levenson AS, Jordan VC 1994 Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines J Steroid Biochem Mol Biol 51:229-239
36. Duan R, Porter W, Safe S 1998 Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Endocrinology 139:1981-1990
37. Castro-Rivera E, Samudio I, Safe S 2001 Estrogen regulation of cyclin D1 gene expression in ZR-75 breast cancer cells involves multiple enhancer elements. J Biol Chem 276:30853-30861
38. Liu MM, Albanese C, Anderson CM, Hilty K, Webb P, Uht RM, Price Jr RH, Pestell RG, Kushner PJ 2002 Opposing action of estrogen receptors α and β on cyclin D1 gene expression. J Biol Chem 277:24353-24360
39. Tremblay GB, Tremblay A, Labrie F, Giguére V 1999 Dominant activity of activation function (AF-1) and differential stochiometric requirements for AF-1 and -2 in the estrogen receptor α-β heterodimeric complex. Mol Cell Biol 19:1919-1927
40. Mader S, Kumar V, de Verneuil H, Chambon P 1989 Three amino acids of the oestrogen receptor are essential to its ability to distinguish an oestrogen from a glucocorticoid-responsive element. Nature 338:271-274
41. Sierralta WD, Bonig I, Thole HH 1995 Immunogold labelling of estradiol receptor in MCF7 cells. Cell Tissue Res 279:445-452
42. Faye JC, Toulas C, Bayard F 1989 Differential estrogenic responsiveness of MCF-7 cells. Relationship to the presence of two different estrogen receptors. J Recept Res 9:203-219
43. Faye JC, Fargin A, Bayard F 1986 Dissimilarities between the uterine estrogen receptor in cytosol of castrated and estradiol-treated rats. Endocrinology 118:2276-2283
44. Fujita T, Kobayashi Y, Wada O, Tateishi Y, Kitada L, Yamamoto Y, Takashima H, Murayama A, Yano T, Baba T, Kato S, Kawabe Y, Yanagisawa J 2003 Full activation of estrogen receptor α activation function-1 induces proliferation of breast cancer cells. J Biol Chem 278:26704-26714
45. Kos M, Denger S, Reid G, Korach KS, Gannon F 2002 Down but not out? A novel protein isoform of the estrogen receptor α is expressed in the estrogen receptor α knockout mouse. J Mol Endocrinol 29:281-286
46. Delaunay F, Pettersson K, Tujague M, Gustafsson JA 2000 Functional differences between the amino-terminal domains of estrogen receptors α and β. Mol Pharmacol 58:584-590
47. Omoto Y, Eguchi H, Yamamoto-Yamaguchi Y, Hayashi S 2003 Estrogen receptor (ER) β1 and ERβcx/β2 inhibit ERα function differently in breast cancer cell line MCF7 Oncogene 22:5011-5020
48. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA 2004 Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 101:1566-1571
49. Teyssier C, Belguise K, Galtier F, Chalbos D 2001 Characterization of the physical interaction between estrogen receptor α and JUN proteins. J Biol Chem 276:36361-36369
50. Kim K, Thu N, Saville B, Safe S 2003 Domains of estrogen receptor α (ERα) required for ERα/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells. Mol Endocrinol 17:804-817
51. Palvimo JJ, Kallio PJ, Ikonen T, Mehto M, Janne OA 1993 Dominant-negative regulation of trans-activation by the rat androgen receptor: roles of the Nterminal domain and heterodimer formation. Mol Endocrinol 7:1399-1407
52. Xing H, Mattick S, Lew D, Shapiro DJ 1995 An N-terminal deletion mutant of estrogen receptor exhibits increased synergism with upstream activators and enhanced binding to the estrogen response element. Biochemistry 34:3956-3963